We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

BIO-RAD LABORATORIES

Provides full range of instrumentation, reagent kits, software and quality control systems to clinical laboratories. ... read more Featured Products: More products

Download Mobile App




Prediabetes Linked to Early Kidney Damage

By LabMedica International staff writers
Posted on 10 Jan 2016
Print article
The fully automated VARIANTII Hemoglobin Testing System
The fully automated VARIANTII Hemoglobin Testing System (Photo courtesy of BIO-RAD LABORATORIES)
The role of prediabetes as a risk factor for hyperfiltration and albuminuria in persons who do not develop diabetes is unclear and the lack of evidence is mainly due to the difficulty of accurately assessing the glomerular filtration rate (GFR) in the near-normal range of GFR.

Diabetes is a major risk factor for kidney disease with around 30% of people with type 1 diabetes and 10%–40% of those with type 2 diabetes will go on to experience kidney failure. New findings suggest that even before a diabetes diagnosis, higher-than-normal blood sugar levels could be causing kidney damage.

Scientists at the University Hospital of North Norway (Tromso, Norway) and their colleagues studied a sample of 1,627 persons aged 50 to 62 years from the general population without self-reported kidney disease, myocardial infarction, stroke, or diabetes. GFR was measured at baseline and follow-up using single-sample plasma iohexol clearance. Serum iohexol was measured by high-performance liquid chromatography.

Serum creatinine analyses were performed using a standardized enzymatic assay, and cystatin C was measured by particle-enhanced turbidimetric immunoassay. GFR was estimated from creatinine or cystatin C levels. Urinary albumin and urinary creatinine excretion were measured with commercial kits. The albumin-creatinine ratio (ACR) was calculated in milligrams per millimole for each urine specimen, and the mean ACR was used in the analyses. HbA1c was measured using liquid chromatography (Variant II instrument; Bio-Rad Laboratories; Hercules CA, USA), and fasting serum glucose was measured on the Modular model P800 (Roche Diagnostics; Basel, Switzerland). Insulin samples were measured with an enzyme-linked immunosorbent assay kit.

In the study, prediabetes was classed as an fasting glucose (FG) level of 110-125 mg/dL (6.1-6.9 mmol/L) and/or a HbA1c level of 6%–6.4%,. The presence of prediabetes among study participants was assessed at study baseline, and subjects were followed-up for a median of 5.6 years. At study baseline, 595 of the participants had prediabetes. After adjusting for participants' lifestyle and use of medications, the scientists found those with prediabetes had a higher measured GFR (mGFR) during follow-up than those without prediabetes, which is a sign of hyperfiltration in the kidneys. The team also found that high FG levels at baseline among these subjects were associated with high levels of the protein albumin in the urine during follow-up, an early sign of kidney disease.

Toralf Melsom, MD, PhD, the lead author of the study said, “Our study shows that the pathological process of kidney injury caused by elevated blood glucose levels starts in prediabetes, well before the onset of diabetes. Prediabetes may be a target for early intervention to prevent chronic kidney disease (CKD) caused by hyperglycemia. If a patient has borderline elevated glucose levels found by their primary physician they should start lifestyle changes with respect to diet and physical activity to preventing diseases like diabetes and kidney disease.” The study was published on December 29, 2015, in the American Journal of Kidney Disease.

Related Links:

University Hospital of North Norway 
Bio-Rad Laboratories 
Roche Diagnostics


New
Gold Member
Rotavirus Test
Rotavirus Test - 30003 – 30073
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Centromere B Assay
Centromere B Test
New
TORCH Infections Test
TORCH Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.